The Geriatric Medicines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Geriatric Medicines Market?
The global market for geriatric medicines has seen considerable growth recently. The market size is set to rise from $1227.91 billion in 2024 to $1430.84 billion in 2025, responding to a compound annual growth rate (CAGR) of 16.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Geriatric Medicines Industry?
The Geriatric Medicines Global Market Report 2025 projects a market size of $2604.86 billion in 2029, with a compound annual growth rate (CAGR) of 16.2%.
Download Your Free Sample of the 2025 Geriatric Medicines Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Geriatric Medicines Market?
The key drivers in the geriatric medicines market are:
•Increasing prevalence of age-related health conditions
•Rising geriatric populations
•Escalating healthcare expenditures
•Growing incidents of hypertension
Global Market Segmentation: Identifying Major Geriatric Medicines Industry Segments
The geriatric medicines market covered in this report is segmented –
1) By Therapeutics: Analgesics, Antihypertensive, Statins, Proton Pump Inhibitors, Anticoagulant, Antipsychotic, Other Therapeutics
2) By Condition: Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory, Other Conditions
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Analgesics: Non-Opioid Analgesics (Acetaminophen, NSAIDs), Opioid Analgesics (Morphine, Oxycodone), Topical Analgesics (Lidocaine Patches)
2) By Antihypertensive: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Beta-Blockers, Calcium Channel Blockers, Diuretics, Alpha-Blockers
3) By Statins: Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, Lovastatin
4) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
5) By Anticoagulant: Warfarin, Direct Oral Anticoagulants (DOACs): Dabigatran, Rivaroxaban, Apixaban, Heparin
6) By Antipsychotic: Atypical Antipsychotics, Typical Antipsychotics
7) By Other Therapeutics: Antidepressants (SSRIs, SNRIs), Antidiabetic Medications (Insulin, Metformin), Anticonvulsants, Anti-Inflammatory Drugs (Corticosteroids), Cognitive Enhancers (Donepezil, Memantine)
Pre-order the 2025 Geriatric Medicines Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Geriatric Medicines Market?
The key trends in the geriatric medicines market are:
•The use of digital pills and wearable health devices is an emerging trend in geriatric medicine.
•There is a developing trend towards creating tools and strategies used for managing multiple medications safely.
•Advancements in stem cell and gene therapy are rapidly shaping the future of this market.
•The expanded use of telehealth platforms and advancements in early diagnosis and prevention of age-related diseases are significant future trends.
Who Are the Top Competitors & Leading Players in the Geriatric Medicines Market?
Major players in the geriatric medicines market are:
• Pfizer Inc.
• Merck & Co. Inc.
• AbbVie Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Regeneron Pharmaceuticals Inc.
• Macleods Pharmaceuticals Ltd.
• Apotex Inc.
• Intas Pharmaceuticals Limited
• Dr. Reddy's Laboratories
• Lupin Limited
• Biocon Limited
• Torrent Pharmaceuticals Ltd.
• Endo Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the geriatric medicines market in 2024
